You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

CORPORATE

A chat with Val Romberg

Kedrion Biopharma's new CEO shares his views

read more 

EVENTS

Turkey, Kedrion supports the XVII International Congress on Hemophilia

The present and future role of Factor VIII at the center of the symposium supported by Kedrion

read more 

EVENTS

Kedrion is one of the main sponsors of the National SISET Conference

The company sponsors two scientific lectures, a testament to its close ties with the world of medicine and science

read more 
  1. EVENTS - 13-07-2015

    Revolutionary PID testing from Tuscany, Italy

    Kedrion at Meyer Hospital’s side to promote early diagnosis of primary immunodeficiencies

    read more 
  2. CORPORATE - 29-06-2015

    Humanitarian programme to reduce the gap in the access to clotting factors

    Kedrion helps the WISH project come true: Italian CNS and the World Federation of Hemophilia sign agreement in London

    read more 
  3. EVENTS - 15-05-2015

    Kedrion Continues Global Expansion with Dedication Ceremony at US Facility

    Biopharma Company Celebrates with Local Guests and Dignitaries in Melville, New York

    read more 
  4. CORPORATE - 30-04-2015

    Kedrion SpA’s Shareholders approve 2014 financial statement

    A 466 million euros’ turnover with a 9,8% rise on 2013

    read more 

Pages

For more information please contact: pressoffice@kedrion.com